Literature DB >> 24759832

Tempered enthusiasm for fecal transplant.

Paola R Solari1, Patrick G Fairchild1, Luis Junco Noa1, Mark R Wallace1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24759832     DOI： 10.1093/cid/ciu278

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  22 in total

Review 1.  Recurrent Clostridium difficile infection and the microbiome.

Authors:  Rowena Almeida; Teklu Gerbaba; Elaine O Petrof
Journal:  J Gastroenterol       Date:  2015-07-08       Impact factor: 7.527

2.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

3.  Fecal microbiota transplant for Clostridium difficile infection in older adults.

Authors:  William M Tauxe; John P Haydek; Paulina A Rebolledo; Emma Neish; Kira L Newman; Angela Ward; Tanvi Dhere; Colleen S Kraft
Journal:  Therap Adv Gastroenterol       Date:  2015-12-31       Impact factor: 4.409

Review 4.  Fecal Microbiota Transfer.

Authors:  Andreas Stallmach; Arndt Steube; Philip Grunert; Michael Hartmann; Lena M Biehl; Maria J G T Vehreschild
Journal:  Dtsch Arztebl Int       Date:  2020-01-17       Impact factor: 5.594

Review 5.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

6.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Zev H Davidovics; Sonia Michail; Maribeth R Nicholson; Larry K Kociolek; Nikhil Pai; Richard Hansen; Tobias Schwerd; Aldo Maspons; Raanan Shamir; Hania Szajewska; Nikhil Thapar; Tim de Meij; Alexis Mosca; Yvan Vandenplas; Stacy A Kahn; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839

7.  Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.

Authors:  Krishna Rao; Kavitha Santhosh; Jill A Mogle; Peter D R Higgins; Vincent B Young
Journal:  Infect Dis (Lond)       Date:  2016-05-20

Review 8.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

Review 9.  Fecal microbiota transplantation for the treatment of Clostridium difficile infection.

Authors:  Krishna Rao; Nasia Safdar
Journal:  J Hosp Med       Date:  2015-09-07       Impact factor: 2.960

10.  Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection.

Authors:  Yvette H van Beurden; Pieter F de Groot; Els van Nood; Max Nieuwdorp; Josbert J Keller; Abraham Goorhuis
Journal:  United European Gastroenterol J       Date:  2016-11-02       Impact factor: 4.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.